Namvar A - Search Results

1

In silico design and in vitro expression of novel multiepitope DNA constructs based on HIV-1 proteins and Hsp70 T-cell epitopes.

Akbari E, Kardani K, Namvar A, Ajdary S, Ardakani EM, Khalaj V, Bolhassani A. Akbari E, et al. Among authors: namvar a. Biotechnol Lett. 2021 Aug;43(8):1513-1550. doi: 10.1007/s10529-021-03143-9. Epub 2021 May 13. Biotechnol Lett. 2021. PMID: 33987776 Free PMC article.

2

Physicochemical properties of polymers: An important system to overcome the cell barriers in gene transfection.

Namvar A, Bolhassani A, Khairkhah N, Motevalli F. Namvar A, et al. Biopolymers. 2015 Jul;103(7):363-75. doi: 10.1002/bip.22638. Biopolymers. 2015. PMID: 25761628

3

HPV16 L2 improves HPV16 L1 gene delivery as an important approach for vaccine design against cervical cancer.

Namvar A, Bolhassani A, Hashemi M. Namvar A, et al. Bratisl Lek Listy. 2016;117(3):179-84. doi: 10.4149/bll_2016_034. Bratisl Lek Listy. 2016. PMID: 26925750

4

Polymorphisms in the TGF-β1 (rs1982037) and IL-2 (rs2069762, rs4833248) genes are not associated with inhibitor development in Iranian patients with hemophilia A.

Naderi N, Ebrahimzadeh F, Jazebi M, Namvar A, Hashemi M, Bolhassani A. Naderi N, et al. Among authors: namvar a. Hematology. 2018 Dec;23(10):839-843. doi: 10.1080/10245332.2018.1498168. Epub 2018 Jul 11. Hematology. 2018. PMID: 29993342 Clinical Trial.

5

Prediction of cross-clade HIV-1 T-cell epitopes using immunoinformatics analysis.

Khairkhah N, Namvar A, Kardani K, Bolhassani A. Khairkhah N, et al. Among authors: namvar a. Proteins. 2018 Dec;86(12):1284-1293. doi: 10.1002/prot.25609. Epub 2018 Nov 1. Proteins. 2018. PMID: 30260061

6

Analysis of long non-coding RNA expression in hemophilia A patients.

Naderi N, Namvar A, Amani N, Nasoohi N, Bolhassani A. Naderi N, et al. Among authors: namvar a. Hematology. 2019 Dec;24(1):255-262. doi: 10.1080/16078454.2018.1560934. Hematology. 2019. PMID: 30758269

7

Inflammatory and immune response genes: A genetic analysis of inhibitor development in Iranian hemophilia A patients.

Naderi N, Yousefi H, Mollazadeh S, Seyed Mikaeili A, Keshavarz Norouzpour M, Jazebi M, Moazezi Nekooi Asl SS, Namvar A, Azizi Saraji A, Agi E, Bolhassani A. Naderi N, et al. Among authors: namvar a. Pediatr Hematol Oncol. 2019 Feb;36(1):28-39. doi: 10.1080/08880018.2019.1585503. Epub 2019 Mar 19. Pediatr Hematol Oncol. 2019. PMID: 30888230 Clinical Trial.

8

In silico/In vivo analysis of high-risk papillomavirus L1 and L2 conserved sequences for development of cross-subtype prophylactic vaccine.

Namvar A, Bolhassani A, Javadi G, Noormohammadi Z. Namvar A, et al. Sci Rep. 2019 Oct 23;9(1):15225. doi: 10.1038/s41598-019-51679-8. Sci Rep. 2019. PMID: 31645650 Free PMC article.

9

Development of HPV_16,18,31,45 E5 and E7 peptides-based vaccines predicted by immunoinformatics tools.

Namvar A, Panahi HA, Agi E, Bolhassani A. Namvar A, et al. Biotechnol Lett. 2020 Mar;42(3):403-418. doi: 10.1007/s10529-020-02792-6. Epub 2020 Jan 8. Biotechnol Lett. 2020. PMID: 31915962 Free PMC article.

10

Impact of Blood Transfusion on the Prevalence of HHpgV-1, HPgV-1, and B19V Among Iranian HCV-infected Patients With Hemophilia.

Agi E, Hojjatipour S, Namvar A, Bolhassani A. Agi E, et al. Among authors: namvar a. J Pediatr Hematol Oncol. 2020 May;42(4):e213-e218. doi: 10.1097/MPH.0000000000001717. J Pediatr Hematol Oncol. 2020. PMID: 31972722 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page